$500 Billion in New U.S. Biopharmaceutical Investment
PhRMA member companies are investing to fuel innovation and bring new jobs to communities across America. Our new investments will deliver a $1.2 trillion boost to the U.S. economy.
Where’s the Drug Dollar Going?
Our current system is inefficient and costs Americans more than it should due to unnecessary bureaucracy. In fact, half of every dollar goes to someone who did not make the medicine.
Novartis Strengthens American Manufacturing Leadership in Radioligand Therapy
Novartis’s new radioligand therapy facilities, including the Carlsbad, California site, expand domestic manufacturing to accelerate the delivery of breakthrough cancer treatments to American patients.
Takeda Powers U.S. Biopharma Leadership and Innovation in Massachusetts
Takeda’s long-standing presence in Massachusetts shows how a supportive local ecosystem drives biopharma growth, translating to economic progress nationwide.
A New Era of Biopharmaceutical Innovation
The biopharmaceutical industry is on the brink of unprecedented breakthroughs, with the potential to revolutionize health care, reduce the burden of disease and create a healthier future for all.
Our Work in Action
To maintain America’s global leadership, we need to support the next generation of innovation in medicine.
